- Report
- February 2025
- 200 Pages
Global
From €4112EUR$4,490USD£3,501GBP
- Report
- March 2024
- 200 Pages
Global
From €3801EUR$4,150USD£3,236GBP
- Report
- May 2025
- 50 Pages
Global
From €2427EUR$2,650USD£2,066GBP
- Report
- May 2025
- 50 Pages
Global
From €2427EUR$2,650USD£2,066GBP
Fenofibric acid is a cardiovascular drug used to treat high cholesterol and triglyceride levels. It is a derivative of fenofibrate, a lipid-lowering agent, and is used to reduce the risk of cardiovascular disease. Fenofibric acid works by increasing the breakdown of triglycerides in the liver, reducing the amount of fat in the blood. It also increases the amount of HDL (good) cholesterol in the blood. Fenofibric acid is available in both capsule and tablet form and is usually taken once a day.
Fenofibric acid is used in combination with other drugs to treat high cholesterol and triglyceride levels. It is also used to reduce the risk of stroke, heart attack, and other cardiovascular events. It is important to note that fenofibric acid should not be used as a substitute for lifestyle changes such as diet and exercise.
Some companies in the Fenofibric Acid market include AbbVie, AstraZeneca, GlaxoSmithKline, Merck, and Pfizer. Show Less Read more